C
Carolyn E. Mountford
Researcher at Translational Research Institute
Publications - 171
Citations - 5812
Carolyn E. Mountford is an academic researcher from Translational Research Institute. The author has contributed to research in topics: Nuclear magnetic resonance spectroscopy & In vivo magnetic resonance spectroscopy. The author has an hindex of 44, co-authored 168 publications receiving 5406 citations. Previous affiliations of Carolyn E. Mountford include National Research Council & University of Sydney.
Papers
More filters
Journal ArticleDOI
Changes in the neurochemistry of athletes with repetitive brain trauma: preliminary results using localized correlated spectroscopy
Alexander P. Lin,Saadallah Ramadan,Robert S. Stern,Hayden C. Box,Christopher J. Nowinski,Brian D. Ross,Carolyn E. Mountford,Carolyn E. Mountford +7 more
TL;DR: A study of a small cohort of professional athletes, with a history of RBT and symptoms of chronic traumatic encephalopathy when compared with healthy controls using 2D L-COSY, showed elevations in brain glutamate/glutamine and choline as recorded previously for early traumatic brain injury.
Journal ArticleDOI
In Vivo Proton MR Spectroscopy of the Breast
TL;DR: In spectra obtained in vivo in malignant breast cancers, an observed resonance at 3.23 ppm is consistent with phosphocholine, and in spectra from benign breast lesions and some normal breast tissue in lactating mothers and in some nonlactating healthy women, a recorded resonance is thought to originate from glycerophosphocholine.
Journal ArticleDOI
Elevated apolipoprotein(a) levels in cancer patients.
Lesley C. Wright,David R. Sullivan,Mark Muller,Marlen Dyne,Martin H.N. Tattersall,Carolyn E. Mountford +5 more
TL;DR: In this article, a significant elevation of total plasma apolipoprotein(a) levels in cancer patients compared with hospitalized control patients and normal healthy blood donors was reported, and 48% had levels in excess of 350 mg/l compared to 20% in normal blood donors and 29% of hospitalized patients.
Journal ArticleDOI
Proton MRS can determine the pathology of human cancers with a high level of accuracy.
TL;DR: The first report of a high-resolution proton proton magnetic resonance spectrum from intact viable cancer cells was made by Block and colleagues in 1973, who suggested 1 H magnetic resonance spectroscopy (MRS) might lead to pathologically relevant information.
Journal ArticleDOI
Cell-surface fucosylation and magnetic resonance spectroscopy characterization of human malignant colorectal cells.
TL;DR: In this article, two-dimensional correlation spectroscopy (COSY) has been used to assess the fucosylation state on the surface of intact viable cells, and differences were recorded between the highly and lowly tumorigenic cell lines.